Sutro Biopharma, Inc. (STRO)
17.10
+1.30
(+8.23%)
USD |
NASDAQ |
Jan 22, 10:20
Sutro Biopharma Free Cash Flow: -225.11M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| GT Biopharma, Inc. | -11.36M |
| Daré Bioscience, Inc. | -17.15M |
| Syndax Pharmaceuticals, Inc. | -311.01M |
| Crinetics Pharmaceuticals, Inc. | -356.03M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -38.19M |
| Cash from Investing (Quarterly) | 39.99M |
| Cash from Financing (Quarterly) | 0.102M |
| Free Cash Flow Per Share (Quarterly) | -4.529 |
| Free Cash Flow to Equity (Quarterly) | -46.30M |
| Free Cash Flow to Firm (Quarterly) | -28.77M |
| Free Cash Flow Yield | -48.62% |